Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent

Published:2004-06-07 Issue:1-3 Volume:569 Page:99-104
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Tamamura Hirokazu,Fujisawa Miho,Hiramatsu Kenichi,Mizumoto Makiko,Nakashima Hideki,Yamamoto Naoki,Otaka Akira,Fujii Nobutaka

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Reference29 articles.

1. Stromal Cell-Derived Factor-1-CXC Chemokine Receptor 4 Interactions Play a Central Role in CD4+T Cell Accumulation in Rheumatoid Arthritis Synovium

2. Molecular cloning and structure of a pre-B-cell growth-stimulating factor.

3. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

4. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies;Expert Opinion on Investigational Drugs;2024-08-08

2. Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review;ACS Pharmacology & Translational Science;2024-05-28

3. Lycium ruthenicum Murr. anthocyanins inhibit hyperproliferation of synovial fibroblasts from rheumatoid patients and the mechanism study powered by network pharmacology;Phytomedicine;2023-09

4. Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial;Nature Medicine;2023-04

5. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis;Frontiers in Immunology;2023-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3